Close

Farmacos Covid19

Famotidine Aids in COVID-19 by Helping Limit Inflammation

Researchers have discovered just how the antacid famotidine, commonly sold as Pepcid by a Johnson & Johnson unit, was able to help alleviate COVID-19 symptoms in clinical trials. In studies in mice, they found that famotidine stimulates the vagus nerve, which controls the immune system and other involuntary body functions. […]

Read More

Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019

Summary Background Human resources for health (HRH) include a range of occupations that aim to promote or improve human health. The UN Sustainable Development Goals (SDGs) and the WHO Health Workforce 2030 strategy have drawn attention to the importance of HRH for achieving policy priorities such as universal health coverage […]

Read More

Evaluación vacuna anti-COVID-19 en niños, manejo de gastroenteritis, y beneficios de la aplicación universal de la vacuna de varicela en México

En esta sección estarán disponibles los resúmenes de artículos recientes, publicados en las principales revistas científicas de pediatría, analizados por el Dr. Jesús Hernández. El Dr. Hernández Tiscareño es egresado de la Benemérita Universidad Autónoma de Puebla y de la Universidad Nacional Autónoma de México, donde cursó un posgrado en […]

Read More

CDC Calls for One Third of Americans to
Mask Up Again

Maybe it was inevitable. In light of both COVID-19 cases and hospitalization numbers rising again, CDC Director Rochelle Walensky, MD, recommends that about a third of Americans mask up again when indoors, when using public transportation, or if you are at high risk for severe COVID-19 illness. The CDC advice […]

Read More

Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel

Multisystem inflammatory syndrome in children (MIS-C) is a serious complication of SARS-CoV-2 infection.1 A previous study that described MIS-C cases in the first 3 waves of the COVID-19 pandemic found that the proportion of individuals with severe illness declined after the first wave.2 In Israel, the Omicron (B.1.1.529) variant started to spread […]

Read More

New White House COVID-19 Leader on What’s Next

Long before he was named the White House’s new COVID-19 czar, Ashish Jha, MD, acknowledged that US strategy to overcome the pandemic needed a new direction. Thanks to safe, effective vaccines, Jha reasoned, it was time to move on from the early goal of trying to prevent every SARS-CoV-2 infection […]

Read More

SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus

SARS-CoV-2, or at least pieces of it, sticks around longer in some infected individuals than respiratory sample testing would suggest, a recent study found. After respiratory samples tested negative, a small proportion of the 113 study participants continued to shed SARS-CoV-2 RNA in their feces—about 4% of them for at least […]

Read More
Translate »